EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global variations in oncology professionals’ confidence levels for managing antibody–drug conjugate toxicities: a cross-continental survey

Marina Campione, Michele Maffezzoli iD, Aruni Ghose, Akash Maniam, Ria Nagpal, Pasquale Rescigno, Sebastiano Buti, Renita George, Kevin Bambury, Richard Bambury, Eoin O'Carroll, Giuseppe Luigi Banna

The Oncologist · 2025

DOI: 10.1093/oncolo/oyaf232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Marina Campione und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Economics and Law of University of Enna Kore, Enna 94100, Italy. Hauptthemen laut MEDLINE: Immunoconjugates, Medical Oncology, Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antibody–drug conjugates (ADCs) represent a promising therapeutic approach in oncology, but managing their toxicities remains challenging. This survey aimed to assess confidence levels in ADC toxicity management among oncology professionals globally.

Methods

A cross-sectional survey was conducted using the ONCOassist mobile, a CE-marked oncology application widely used by oncologists globally as support in clinical practice. Confidence in toxicity management was measured on a 5-point scale. Predictor variables included income level, professional role, specialization, and cancer type treated.

Results

The survey was offered to 5883 users, and responses were received from 1256 oncology healthcare professionals (HCPs) across various continents and professional roles. Medical oncologists represented the largest group (46%). Most of the HCPs were from high- or upper-middle-income countries (75%) with most nurses (86%) from high-income countries. Respondents from Europe and North America reported higher confidence ratings, while those from Asia, Africa, and Oceania tended to report lower confidence levels (P < .001). Respondents from lower-middle-income countries reported lower confidence compared with those from high- and upper-middle-income countries (P < .001). Additionally, senior physicians exhibited substantially higher confidence compared to junior physicians and nurse practitioners (P < .001, for both). Specialty affected confidence levels, particularly in surgical oncologists who reported the lowest confidence (P < .001).

Conclusion

This global survey reveals significant disparities in confidence levels for managing ADC toxicities across regions, professional roles, and specializations. These findings may suggest the need for targeted educational interventions and support systems to enhance competences in managing ADC-related toxicities, ultimately improving the global standard of care for patients receiving ADCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesMedical OncologyNeoplasmsHumansCross-Sectional StudiesSurveys and QuestionnairesFemaleMaleHealth PersonnelOncologistsAdultMiddle Aged

Stichwörter der Autor:innen

ADCadverse eventsappcancersurveytoxicity

Substanzen

Immunoconjugates

Autor:innen und Institutionen

  • Faculty of Economics and Law of University of Enna Kore, Enna 94100, Italy.
  • Portsmouth Hospitals University NHS Trust, Portsmouth PO6 3LY, United Kingdom.
  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom.

ORCID-Profile: Michele Maffezzoli

Förderung

  • AstraZeneca

Zitieren

APA

Campione, M., Maffezzoli, M., Ghose, A., Maniam, A., Nagpal, R., Rescigno, P., Buti, S., George, R., Bambury, K., Bambury, R., O'Carroll, E., & Banna, G. L. (2025). Global variations in oncology professionals’ confidence levels for managing antibody–drug conjugate toxicities: a cross-continental survey. The Oncologist. https://doi.org/10.1093/oncolo/oyaf232

Vancouver

Campione M, Maffezzoli M, Ghose A, Maniam A, Nagpal R, Rescigno P, et al. Global variations in oncology professionals’ confidence levels for managing antibody–drug conjugate toxicities: a cross-continental survey. The Oncologist. 2025. doi:10.1093/oncolo/oyaf232

BibTeX
@article{Campione2025,
  author = {Campione, Marina and Maffezzoli, Michele and Ghose, Aruni and Maniam, Akash and Nagpal, Ria and Rescigno, Pasquale and Buti, Sebastiano and George, Renita and Bambury, Kevin and Bambury, Richard and O'Carroll, Eoin and Banna, Giuseppe Luigi},
  title = {Global variations in oncology professionals’ confidence levels for managing antibody–drug conjugate toxicities: a cross-continental survey},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyaf232}
}
Kostenlos starten →